Public Calendar: April 9 - 15, 2017
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Stephen M. Ostroff, M.D., Acting Commissioner of Food and Drugs
No Significant Event
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
Event Date : 04/13/2017 - 04/13/2017
Location : Washington, DC
Subject : Drug Pricing
FDA Participant/Group : JOHN KALAVRITINOS;
Non FDA Participant/Group : Alicia Hennie, Jay Taylor, Jim Stanel, Kelly Goldberg, Lisa Joldersma, Lori Reilly, Randy Burkholder, Rodger Currie, Sylvia Yu (Pharmaceutical Research and Manufacturers of America); Kyle McGowan (HHS Intergovermental and External Affairs); John Graham, John O'Brien (HHS Assistant Secretary for Planning and Evaluation); Amanda Street, John Brooks, Paula Stannard (HHS Office of the Secretary);
Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name : Jim Sigg, Acting Deputy Commissioner for Operations
No Significant Event
Official Name : Erik Mettler, Acting Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs
No Significant Event
Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs
No Significant Event
Official Name : Luciana Borio, M.D., Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date : 04/11/2017 - 04/11/2017
Location : Arlington, VA
Subject : An Introduction to the Glioblastoma Multiforme (GBM) Adaptive Global Innovative Learning Environment (AGILE) Trial
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date : 04/13/2017 - 04/13/2017
Location : Minneapolis, MN
Subject : Presented at the Design of Medical Devices Conference
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date : 04/11/2017 - 04/11/2017
Location : Washington DC
Subject : 40th Annual National Food Policy Conference (Keynote Speaker) FDA Policy
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
Event Date : 04/12/2017 - 04/12/2017
Location : Rockville, Maryland
Subject : Center for Veterinary Medicine Overview
FDA Participant/Group : TRACEY FORFA; WILLIAM FLYNN; STEVEN VAUGHN; NADINE STEINBERG; DANIEL MCCHESNEY;
Non FDA Participant/Group : Karin Hoelzer, Kathy Talkington, Kyle Kinner, Nora Wong (Pew Charitable Trusts);
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date : 04/11/2017 - 04/11/2017
Location : Jefferson, Arkansas
Subject : Visit to the National Center for Toxicological Research
FDA Participant/Group : N/A
Non FDA Participant/Group : Representative Bruce Westerman (R-AR);
Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel
No Significant Event